The effect of Iris tablet on adult asthma

A clinical trial comparing the effect of Iris and placebo on clinical symptoms in patients with adult asthma: A double-blind, randomized study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200303046677N4

Enrollment

Registered

2021-01-13

Start date

2021-03-20

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthma

Interventions

Intervention 1: Intervention group: Iris group

8 Kg of Iris root, 2 kg of black pepper, and 2 kg of Valeriana officinalis are ground, 2 kg of Dorema ammoniacum gum is dissolved in vinegar and then filtered and dried in an oven, and the result is g

The placebo was prepared from corn starch in the same color and size capsules. Placebo was used similarly to the drug used by the intervention group.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Slight to moderate asthma Age between 18 to 60 years old

Exclusion criteria

Exclusion criteria: Severe asthma and requires hospitalization Patients with underlying diseases such as COPD, CHF, heart failure, GERD, bronchiectasis, pulmonary embolism, sarcoidosis Smokers BMI> 29 Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Shortness of breath. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Cough. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Wheezing. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Sputum. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Spray consumption. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;The rate of backwardness from daily tasks. Timepoint: At the beginning of the study. At the end of the fourth and eighth week. Method of measurement: Asthma Control Test questionnaire.;Rate of waking up early in the morning due to shortness of breath. Timepoint: At the beginning of the study. At the end of the fourth and eighth week. Method of measurement: Asthma Control Test questionnaire.;The rate of not sleeping at night due to shortness of breath. Timepoint: At the beginning of the study. At the end of the fourth and eighth week. Method of measurement: Asthma Control Test questionnaire.;Chest pain or tightness. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Feeling heavy in the chest. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.	—

Measure

Time frame

Shortness of breath. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Cough. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Wheezing. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Sputum. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Spray consumption. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;The rate of backwardness from daily tasks. Timepoint: At the beginning of the study. At the end of the fourth and eighth week. Method of measurement: Asthma Control Test questionnaire.;Rate of waking up early in the morning due to shortness of breath. Timepoint: At the beginning of the study. At the end of the fourth and eighth week. Method of measurement: Asthma Control Test questionnaire.;The rate of not sleeping at night due to shortness of breath. Timepoint: At the beginning of the study. At the end of the fourth and eighth week. Method of measurement: Asthma Control Test questionnaire.;Chest pain or tightness. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.;Feeling heavy in the chest. Timepoint: At the beginning of the study; At the end of the fourth and eighth weeks. Method of measurement: Asthma Control Test questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactrasool choopani

Shahid Beheshti University of Medical Sciences

rchoopani@sbmu.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026